-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615.O2.3 615. Acute Myeloid Leukemias: Clinical and Epidemiological: Frailty, Age, and Care Provisions-Impact on AML Outcomes

Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Clinical trials, Adult, Clinical Practice (Health Services and Quality), Elderly, Clinical Research, Health outcomes research, Supportive Care, Diseases, Treatment Considerations, Real-world evidence, Lymphoid Malignancies, Adverse Events, Myeloid Malignancies, Study Population, Human
Sunday, December 8, 2024: 9:30 AM-11:00 AM
Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Moderators:
Rory M. Shallis, MD, Yale School of Medicine - Yale Cancer Center and Daisuke Tomizawa, MD, PhD, National Center for Child Health and Development
Disclosures:
Tomizawa: Nihon Servier: Honoraria; Otsuka Pharmaceutical: Honoraria; Miyarisan Pharmaceutical Co., Ltd.: Honoraria; Astellas Pharma Inc.: Honoraria; Taiho Pharma: Honoraria; Abbvie Inc.: Honoraria; Amgen Inc.: Honoraria; Pfizer Japan Inc.: Honoraria; Nippon Shinyaku Co., Ltd.: Honoraria; Novartis: Honoraria; Meiji Seika Pharma: Consultancy, Honoraria.
9:30 AM

Leora Boussi, MD1, Hannah Burton2*, Andriy Derkach, PhD3*, David Nemirovsky3*, Jenna Ciervo, PharmD4*, Martin S. Tallman, MD5, Eytan M. Stein, MD6 and Sheng Cai, MD, PhD4

1Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Drexel University College of Medicine, Philadelphia, PA
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Highland Park, IL
6Department of Medicine; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY

9:45 AM

Ian M. Bouligny, MD1, Hagop M. Kantarjian, MD1, Musa Yilmaz, MD1*, Naval Daver, MD2, Gautam Borthakur, MD3, Courtney D. DiNardo, MD, MSc1, Guillermo Montalban-Bravo, MD1, Nicholas J. Short, MD1, Yesid Alvarado Valero, MD1, Nitin Jain, MD1, Naveen Pemmaraju, MD4, Danielle Hammond, MD1, Kelly S. Chien, MD5, Koichi Takahashi, MD, PhD6, Ghayas C. Issa, MD1, Hussein A. Abbas, MD, PhD1, Elias Jabbour, MD1, Guillermo Garcia-Manero, MD1, Farhad Ravandi, MBBS7 and Tapan M. Kadia, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2MD Anderson Cancer Center, Houston, TX
3Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Bellaire, TX
5Department of Leukemia, MD Anderson, Houston, TX
6Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX

10:00 AM

Samuel J. Yates, MD, MSc1, Julian J. Weiss, MD2*, Abigail Sneider, MD3*, Emily Geramita, MD, PhD4, Guru Subramanian Guru Murthy, MBBS5, Talha Badar, MD6, Annie Im, MD7, Chenyu Lin, MD8, Wei Cheng, PhD9*, Eric S. Winer, MD10, Yasmin Abaza, MD11, Mark R. Litzow, MD12, Ehab L. Atallah, MD5, Alok Swaroop, MD, PhD13*, Anand Ashwin Patel, MD1 and Rory M. Shallis, MD14

1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
2Department of Internal Medicine, Duke University Medical Center, Durham, NC
3University of Chicago Pritzker School of Medicine, Chicago, IL
4UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA
5Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
6Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
7UPMC Hillman Cancer Center, Univ. of Pittsburgh Cancer Institute, Pittsburgh, PA
8Duke University Cancer Institute, Durham, NC
9Department of Biostatistics, Yale School of Public Health, New Haven, CT
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
11Northwestern University, Chicago, IL
12Division of Hematology, Mayo Clinic, Rochester, MN
13Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
14Department of Internal Medicine, Section of Hematology, Yale School of Medicine - Yale Cancer Center, Killingworth, CT

10:15 AM

Clark DuMontier, MD, MPH1,2,3*, Angel Cronin, MS4*, Tammy T Hshieh, MD, MPH2,3*, Ameya Sanyal, BA2*, Michelle Fredericks, MPH2*, Nicholas Groblewski, BA2*, Lee Mozessohn, MD5, Daniel J DeAngelo, MD, PhD2,3, Richard M Stone, MD2,3, Robert J. Soiffer, MD2,3, Jane A Driver, MD, MPH1,3* and Gregory A Abel, MD, MPH3,6

1Veterans Affairs Boston Healthcare System, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Brigham and Women's Hospital, Boston, MA
4Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
5Sunnybrook Health Sciences Centre, Toronto, ON, Canada
6Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

10:30 AM

Gopila Gupta1*, Sho Podolsky2*, Ning Liu, PhD3*, Matthew C. Cheung, MD, MSc4 and Aniket Bankar, MD, MBBS, MSc, DM1

1Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada
2Institute for Clinical Evaluative Sciences (ICES), Toronto, ON, Canada
3ICES, Toronto, ON, Canada
4Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

10:45 AM

Andrew Zale, MD1*, Alexander J. Ambinder, MD, MPH2 and Venkata Preetam Sandeep Kaduluri, MBBS, MPH3*

1Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
3Sidney Kimmel Comprehensive Cancer Center/Division of Hematological Malignancies and Bone Marrow Transplantation, Johns Hopkins Hospital, Baltimore, MD

*signifies non-member of ASH